Great work by @JacobsenLM and @Heba_T1D supporting the idea that metabolic endpoints can give us a quick readout of T1D disease modification. And we know based on @DrPeteTaylor and Colin Dayan's data that these changes have clinical relevance for our …
RT @DiabetesCareADA: @T1D_TrialNet identifies earlier trial end points that demonstrate a beneficial treatment effect at 6 months and predi…
RT @DiabetesCareADA: @T1D_TrialNet identifies earlier trial end points that demonstrate a beneficial treatment effect at 6 months and predi…
RT @DiabetesCareADA: @T1D_TrialNet identifies earlier trial end points that demonstrate a beneficial treatment effect at 6 months and predi…